Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for recurrent primary sclerosing cholangitis after liver transplantation
IRCT20120731010453N7Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin in Primary Sclerosing Cholangitis (PSC), sponsored by Shiraz University of Medical Sciences. Started Jul 2025; status: completed.
02
Drugs
curcumin
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on IRCT20120731010453N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120731010453N7.